Factory Wholesale Tirzepatide Weight Loss peptide powder price 5mg 15mg for sale Injection
Product ID: Phcoker02
Send Inquiry
What is Tirzepatide?
Tirzepatide is a novel, once-weekly injectable medication being developed by Eli Lilly and Company for the treatment of type 2 diabetes. It is marketed under the brand name Mounjaro,received FDA approval on May 13, 2022. Tirzepatide acts as a dual agonist for GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. GIP stimulates insulin release and inhibits glucagon, while GLP-1 enhances insulin secretion, suppresses glucagon, and promotes fullness. Tirzepatide’s combined action optimizes blood sugar control, as insulin uptake increases and glucose production decreases. The synergy of GIP and GLP-1 mechanisms may lead to improved glycemic management and weight loss. Tirzepatide’s innovative approach harnesses the benefits of both hormones, making it a promising therapeutic option for individuals with type 2 diabetes and obesity, addressing multiple aspects of metabolic regulation.
Tirzepatide is a novel, once-weekly injectable medication being developed by Eli Lilly and Company for the treatment of type 2 diabetes. It is marketed under the brand name Mounjaro,received FDA approval on May 13, 2022. Tirzepatide acts as a dual agonist for GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptors. GIP stimulates insulin release and inhibits glucagon, while GLP-1 enhances insulin secretion, suppresses glucagon, and promotes fullness. Tirzepatide’s combined action optimizes blood sugar control, as insulin uptake increases and glucose production decreases. The synergy of GIP and GLP-1 mechanisms may lead to improved glycemic management and weight loss. Tirzepatide’s innovative approach harnesses the benefits of both hormones, making it a promising therapeutic option for individuals with type 2 diabetes and obesity, addressing multiple aspects of metabolic regulation.
Main Products
Peptide